首页> The New England journal of medicine> Inebilizumab for Treatment of IgG4-Related Disease.

Inebilizumab for Treatment of IgG4-Related Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： John H,Stone

第一单位： Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.

作者： John H,Stone ^[1] ; Arezou,Khosroshahi ^[2] ; Wen,Zhang ^[3] ; Emanuel,Della Torre ^[4] ; Kazuichi,Okazaki ^[5] ; Yoshiya,Tanaka ^[6] ; J Matthias,Löhr ^[7] ; Nicolas,Schleinitz ^[8] ; Lingli,Dong ^[9] ; Hisanori,Umehara ^[10] ; Marco,Lanzillotta ^[4] ; Zachary S,Wallace ^[1] ; Mikael,Ebbo ^[8] ; George J,Webster ^[11] ; Fernando,Martinez Valle ^[12] ; Manu K,Nayar ^[13] ; Cory A,Perugino ^[1] ; Vinciane,Rebours ^[14] ; Xinxin,Dong ^[15] ; Yanping,Wu ^[15] ; Qing,Li ^[15] ; Nishi,Rampal ^[15] ; Daniel,Cimbora ^[15] ; Emma L,Culver ^[16] ; MITIGATE Trial Investigators

作者单位： Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston. ^[1] Division of Rheumatology, Emory University School of Medicine, Atlanta. ^[2] Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing. ^[3] Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan. ^[4] Department of Internal Medicine, Kansai Medical University Kori Hospital, Osaka, Japan. ^[5] First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. ^[6] Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm. ^[7] Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Centre National de la Recherche Scientifique, INSERM, Centre d'Immunologie de Marseille-Luminy, Hopital de la Timone, Internal Medicine Department, Marseille, France. ^[8] Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[9] Nagahama City Hospital, Nagahama, Japan. ^[10] Department of Gastroenterology, University College London Hospitals, London. ^[11] Internal Medicine Department, Vall d'Hebron Hospital, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona. ^[12] Hepato-Pancreato-Biliary Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom. ^[13] Pancreatology and Digestive Oncology Department, Beaujon Hospital, Université Paris Cité, Clichy, France. ^[14] Amgen, Thousand Oaks, CA. ^[15] Translational Gastroenterology and Liver Unit, John Radcliffe Hospital, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. ^[16]